Screening blood donors for hereditary hemochromatosis: Decision analysis model comparing genotyping to phenotyping

American Journal of Gastroenterology

Volumn 94, Issue 6, 1999, Pages 1593-1600

  Adams, Paul C ^a   Valberg, Leslie S ^b  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

IRON;

ARTICLE; BLOOD DONOR; CONTROLLED STUDY; COST UTILITY ANALYSIS; DECISION THEORY; FEMALE; GENETIC SCREENING; GENOTYPE; HEMOCHROMATOSIS; HUMAN; HUMAN TISSUE; IRON OVERLOAD; MALE; MISSENSE MUTATION; PHENOTYPE; PRIORITY JOURNAL;

BLOOD DONORS; DECISION SUPPORT TECHNIQUES; DECISION TREES; GENETIC SCREENING; GENOTYPE; HEALTH CARE COSTS; HEMOCHROMATOSIS; HUMANS; MUTATION; PHENOTYPE; SENSITIVITY AND SPECIFICITY;

EID: 0033050583     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1999.1120_f.x     Document Type: Article

References (51)

1. Simon M., Bourel M., Fauchet R., et al. HLA and "non-immunological" disease Idiopathic haemochromatosis . Lancet. 1:1976;973-974.
2. Borwein S.T., Ghent C.N., Flanagan P.R., et al. Genetic and phenotypic expression of hemochromatosis in Canadians. Clin Invest Med. 6:1983;171-179.
3. Edwards C.Q., Griffen L.M., Goldgar D., et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med. 318:1988;1355-1362.
4. Hallberg L., Bjorn-Rasmussen E., Jungner I. Prevalence of hereditary haemochromatosis in two Swedish urban areas. J Intern Med. 225:1989;249-255.
5. Edwards C.Q., Kushner J.P. Screening for hemochromatosis. N Engl J Med. 328:1993;1616-1620.
6. Niederau C., Fischer R., Sonnenberg A., et al. Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis. N Engl J Med. 313:1985;1256-1262.
7. Adams P.C., Kertesz A.E., Valberg L.S. Clinical presentation of hemochromatosis A changing scene . Am J Med. 90:1991;445-449.
8. Adams P.C., Speechley M., Kertesz A.E. Long-term survival analysis in hereditary hemochromatosis. Gastroenterology. 101:1991;368-372.
9. Phatak P.D., Guzman G., Woll J.E., et al. Cost-effectiveness of screening for hereditary hemochromatosis. Arch Intern Med. 154:1994;769-776.
10. Bassett M., Leggett B.A., Halliday J.W., et al. Analysis of the cost of population screening for haemochromatosis using biochemical and genetic markers. J Hepatology. 27:1997;517-524.
11. Bassett M.L., Doran T.J., Halliday J.W., et al. Idiopathic hemochromatosis Demonstration of homozygous-heterozygous mating by HLA typing of families . Hum Genet. 60:1982;352-356.
12. Beaumont C., Simon M., Fauchet R., et al. Serum ferritin as a possible marker of the hemochromatosis allele. N Engl J Med. 301:1979;169-174.
13. Dadone M.M., Kushner J.P., Edwards C.Q., et al. Hereditary hemochromatosis. Analysis of laboratory expression of the disease by genotype in 18 pedigrees. Am J Clin Pathol. 78:1982;196-207.
14. Summary of a report on assessment of the iron nutritional status of the United States population. Am J Clin Nutr. 42:1985;1318-1330.
15. Tanner A.R., Wright R. Hemochromatosis screening. Lancet. 2:1988;286.
16. Lindmark B., Eriksson S. Prevalence of hemochromatosis. N Engl J Med. 319:1988;1548-1549. (letter).
17. Leggett B.A., Halliday J.W., Brown N.N., et al. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol. 74:1990;525-530.
18. Wiggers P., Dalhoj J., Petersen P.H., et al. Screening for hemochromatosis Influence of analytical imprecision, diagnostic limit and prevalence on test validity . Scand J Clin Invest. 51:1991;143-148.
19. Jonsson J.J., Johannesson G.M., Sigfusson N., et al. Prevalence of iron deficiency and iron overload in the adult Icelandic population. J Clin Epidemiol. 44:1991;1289-1297.
20. Wiggers P., Dalhoj J., Kiaer H., et al. Screening for haemochromatosis Prevalence among Danish blood donors . J Intern Med. 230:1991;265-270.
21. Baynes R.D., Meyer T.E., Bothwell T.H., et al. A screening test for detecting iron overload in population studies. S Afr Med J. 74:1988;167-169.
22. Borwein S., Ghent C.N., Valberg L.S. Diagnostic efficacy of screening tests for hereditary hemochromatosis. Can Med Assoc J. 131:1984;895-901.
23. Bassett M.L., Halliday J.W., Bryant S., et al. Screening for hemochromatosis. Ann NY Acad Sci. 526:1988;274-289.
24. Bassett M.L., Halliday J.W., Ferris R.A., et al. Diagnosis of hemochromatosis in young subjects Predictive accuracy of biochemical screening tests . Gastroenterology. 87:1984;628-633.
25. Niederau C., Niederau C.M., Lange S., et al. Screening for hemochromatosis and iron deficiency in employees and primary care patients in Western Germany. Ann Int Med. 128:1998;337-345.
26. Feder J.N., Gnirke A., Thomas W., et al. A novel MHC class I-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet. 13:1996;399-408.
27. Jazwinska E.C., Cullen L.M., Busfield F., et al. Haemochromatosis and HLA-H. Nat Genet. 14:1996;249-251.
28. Jouanolle A.-M., Gandon G., Jezequel P., et al. Haemochromatosis and HLA-H. Nat Genet. 14:1996;251-252.
29. Adams P.C., Gregor J.C., Kertesz A.E., et al. Screening blood donors for hereditary hemochromatosis Decision analysis model based on a thirty-year database . Gastroenterology. 109:1995;177-188.
30. Adams P.C., Kertesz A., Valberg L.S. Screening for hemochromatosis in children of homozygotes Prevalence and cost-effectiveness . Hepatology. 22:1995;1720-1727.
31. Adams P.C., Kertesz A.E., Barr R., et al. Population screening for hemochromatosis with the unbound iron binding capacity. Gastroenterology. 114:1998;A1199. (abstract).
32. Adams P.C., Speechley M. The effect of arthritis on the quality of life in hereditary hemochromatosis. J Rheumatol. 23:1996;707-710.
33. Niederau C., Fischer R., Purschel A., et al. Long-term survival in patients with hereditary hemochromatosis. Gastroenterology. 110:1996;1107-1119.
34. Bulaj Z.J., Griffen L., Jorde L.B., et al. Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Eng J Med. 335:1996;1799-1805.
35. Adams P.C. Prevalence of abnormal iron studies in heterozygotes for hereditary hemochromatosis - An analysis of 255 heterozygotes. Am J Hematol. 45:1994;146-149.
36. Bassett M.L., Halliday J.W., Powell L.W. HLA typing idiopathic hemochromatosis Distinction between homozygotes and heterozygotes with biochemical expression . Hepatology. 1:1981;120-126.
37. Pietrangelo A., Montosi G., Garuti C., et al. No HFE, No HLA, No 6p-linked adult hemochromatosis A new genetic iron overload condition . Hepatology. 28:1998;528A. (abstract).
38. Adams P.C., Bradley C., Henderson A.R. Evaluation of the hepatic iron index as a diagnostic criterion in hereditary hemochromatosis. J Lab Clin Med. 130:1997;509-514.
39. A simple genetic test identifies 90% of UK patients with haemochromatosis. Gut. 41:1997;841-845.
40. Burke W., Thomson E., Khoury M., et al. Hereditary hemochromatosis Gene discovery and its implications for population-based screening . JAMA. 280:1998;172-178.
41. Carella M., D'Ambrosio L., Totaro A., et al. Mutation analysis of the HLA-H gene in Italian hemochromatosis patients. Am J Hum Genet. 60:1997;828-832.
42. Adams P.C., Chakrabarti S. Genotypic/phenotypic correlations in genetic hemochromatosis Evolution of diagnostic criteria . Gastroenterology. 114:1998;319-323.
43. Oliver M., Scully L., Guiraudon C., et al. Non-HLA linked hemochromatosis in a Chinese woman. Dig Dis Sci. 40:1995;1589-1591.
44. Eason R.J., Adams P.C., Aston C.E., et al. Familial iron overload with possible autosomal dominant inheritance. Aust NZ J Med. 20:1990;226-230.
45. Gordeuk V., Mukiibi J., Hasstedt S.J., et al. Iron overload in Africa. Interaction between a gene and dietary iron content. N Engl J Med. 326:1992;95-100.
46. Morita H., Ikeda S., Yamamoto K., et al. Hereditary ceruloplasmin deficiency with hemosiderosis A clinicopathological study of a Japanese family . Ann Neurol. 37:1995;646-656.
47. Wurapa R.K., Gordeuk V., Brittenham G., et al. Primary iron overload in African Americans. Am J Med. 100:1996;9-18.
48. Baer D.M., Simons J.L., Staples R.L., et al. Hemochromatosis screening in asymptomatic ambulatory men 30 years of age and older. Am J Med. 98:1995;464-468.
49. Adams P.C., Campion M.L., Gwandon G., et al. Clinical and family studies in genetic hemochromatosis Microsatellite and HFE studies in five atypical families . Hepatology. 26:1997;986-990.
50. Fargion S., Fracanzani A.L., Piperno A., et al. Prognostic factors for hepatocellular carcinoma in genetic hemochromatosis. Hepatology. 20:1994;1426-1431.
51. Guyader D., Jacquelinet C., Moirand R., et al. Non-invasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology. 115:1998;929-936.